Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) shares traded down 2.1% during mid-day trading on Wednesday . The stock traded as low as $17.58 and last traded at $17.85. 54,362 shares were traded during mid-day trading, a decline of 69% from the average session volume of 177,312 shares. The stock had previously closed at $18.23.
Ascentage Pharma Group International Stock Down 2.1 %
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Further Reading
- Five stocks we like better than Ascentage Pharma Group International
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Where Do I Find 52-Week Highs and Lows?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
